Skip to Content
Know what to ask with our GIST Doctor Discussion Guide

Florbetaben f-18 Pregnancy and Breastfeeding Warnings

Florbetaben f-18 is also known as: Neuraceq

Florbetaben f-18 Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: C Comments: Assess pregnancy status before administering this drug to a female of reproductive potential. All radiopharmaceuticals have a potential to cause fetal harm. The likelihood of fetal harm depends on the stage of fetal development and the magnitude of the radiopharmaceutical dose.

Animal reproduction studies have not been conducted with this drug. It is not known whether this drug can cause fetal harm when administered to a pregnant woman or if it can affect reproduction capacity. Animal reproduction studies have not been conducted with this drug. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Florbetaben f-18 Breastfeeding Warnings

Use should be avoided. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: Temporarily interrupt breastfeeding for 24 hours after exposure to florbetaben. The patient should pump and discard breast milk and use other nutrition sources (e.g. stored breast milk or infant formula) for 24 hours after the administration of this drug.

See references

References for pregnancy information

  1. "Product Information. Neuraceq (florbetaben F-18)." IBA Molecular North America Inc, Dulles, VA.

References for breastfeeding information

  1. "Product Information. Neuraceq (florbetaben F-18)." IBA Molecular North America Inc, Dulles, VA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide